Clearpoint Neuro Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -24.5% | -26.7% | +87.8% | -43.5% | +51.8% | +147.5% | +122.2% | -15.4% | -23.1% | -8.1% | +149.4% | |
| – | -27.1% | -28.7% | +109.5% | -47.8% | +56.0% | +145.2% | +143.1% | -17.3% | -29.3% | -7.8% | +90.6% | |
| – | -41.5% | -38.7% | +180.2% | -66.6% | +83.7% | +252.9% | +169.2% | -49.0% | -16.2% | -13.1% | +128.4% | |
| – | -41.5% | -38.7% | +180.2% | -66.6% | +83.7% | +252.9% | +169.2% | -30.7% | -38.3% | -13.1% | +128.4% | |
| – | +159.7% | -28.9% | +9.6% | +30.0% | -11.7% | +72.6% | +24.2% | +14.0% | +48.0% | +19.5% | +54.1% | |
| – | -8.0% | -2.2% | +30.9% | -9.0% | +53.8% | -0.1% | +52.5% | +88.4% | -15.0% | -13.2% | +21.8% | |
| – | – | -25.5% | -18.5% | +41.1% | +117.4% | +272.1% | -9.0% | -54.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -24.9% | +287.9% | +1.3% | -53.5% | +2,776.4% | |
| – | -10.4% | -32.5% | -1.1% | -21.4% | +15.7% | +269.7% | -38.1% | +10.8% | +15.5% | -35.8% | +405.3% | |
| – | +55.6% | -60.6% | +45.7% | -54.4% | +90.9% | -16.5% | +48.5% | +42.8% | +9.5% | +39.3% | +4.0% | |
| – | – | -73.6% | +79.1% | – | – | +245.6% | +28.7% | +10.7% | -24.4% | +31.4% | +24.6% | |
| – | -30.0% | +121.7% | -50.9% | -34.0% | +92.8% | -68.9% | +42.3% | -36.3% | +44.5% | +241.0% | -6.3% | |
| – | – | +20.7% | -35.0% | +19.3% | -40.5% | +926.7% | -53.8% | +0.6% | +0.6% | – | – | |
| – | – | – | – | -74.1% | +203.5% | -48.2% | +1,952.5% | -24.4% | -42.6% | +19.9% | +10.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.3% | +46.2% | +180.9% | +41.2% | +20.4% | +20.5% | +30.8% | +16.6% | +1.8% | +9.8% | +4.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.